#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	9770	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2007	479.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	547	C	539	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3599	497.7	0	.	n	.	0	A20C	SNP	20	20	A	353	353	C	352	C,A	305,39	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3599	497.7	0	.	n	.	0	T695C	SNP	695	695	T	1028	1028	C	542	C	526	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3599	497.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1971	1971	G	634	G,A	585,35	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3599	497.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2304	2304	C	588	C,G	570,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3599	497.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2378	2378	A	559	A,C	545,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3599	497.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2930	2930	C	537	C	525	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3599	497.7	0	HET	.	.	.	A412G,T	.	412	412	A	745	745	A	539	A,G,T	396,113,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1314	folP	855	855	100.0	folP.l6.c4.ctg.1	1648	79.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1164	1166	AGC	121;121;119	A;G;C	117;118;115	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3574	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3474	102.4	1	SNP	p	S91F	1	.	.	271	273	TTC	573	575	TTC	131;133;131	T;T;C	130;132;130	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3574	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3474	102.4	1	SNP	p	G95N	0	.	.	283	285	GGC	585	587	GGC	124;124;124	G;G;C	121;120;122	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3574	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3474	102.4	1	SNP	p	D95G	1	.	.	283	285	GGC	585	587	GGC	124;124;124	G;G;C	121;120;122	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1104	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1294	84.3	0	.	p	.	0	F184L	NONSYN	550	552	TTC	872	874	TTG	113;112;112	T;T,G;G,C	109;108,1;100,9	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1104	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1294	84.3	1	SNP	p	G45D	0	.	.	133	135	GGC	455	457	GGC	138;136;135	G;G;C	138;136;133	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	636	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	904	69.5	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	146	A	144	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	115.3	1	SNP	p	D86N	0	.	.	256	258	GAC	515	517	GAC	139;141;142	G;A,C;C	135;133,1;138	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	115.3	1	SNP	p	R87I	0	.	.	259	261	CGT	518	520	CGT	140;142;144	C;G;T	136;137;141	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	115.3	1	SNP	p	R87W	0	.	.	259	261	CGT	518	520	CGT	140;142;144	C;G;T	136;137;141	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	115.3	1	SNP	p	S87R	1	.	.	259	261	CGT	518	520	CGT	140;142;144	C;G;T	136;137;141	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	115.3	1	SNP	p	S88P	0	.	.	262	264	TCC	521	523	TCC	143;142;142	T,C;C;C	139,1;138;137	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2768	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2801	98.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1605	1607	GGC	142;143;142	G;G;C	139;137;136	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1259	1261	GCA	126;127;128	G;C;A,C	123;122;122,2	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1262	1264	ATC	128;128;128	A,T;T;C,G	124,1;122;121,2	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1274	1276	GTG	127;126;124	G,A;T,C;G,C	122,2;120,2;119,2	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1274	1276	GTG	127;126;124	G,A;T,C;G,C	122,2;120,2;119,2	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1778	1780	ACC	133;134;133	A,G;C;C,T	132,1;133;132,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1832	1834	GCG	108;107;108	G;C;G	95;93;96	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1832	1834	GCG	108;107;108	G;C;G	95;93;96	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1955	1957	AGC	91;90;91	A,G,C;G;C,T	82,6,1;88;84,5	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1964	1966	GGC	80;80;81	G,A;G;C	70,7;78;79	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2544	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	104.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1982	1984	CCG	72;73;74	C,G;C;G,GGGC	63,2;65;58,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	3550	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3216	109.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1721	1723	CTG	129;128;130	C,G;T,C;G	123,1;121,3;126	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1682	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1885	88.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	97	C	90	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	93	95	TTA	33;33;33	T;T;A	31;32;31	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	138	140	CAT	30;28;27	C,G;A;T	27,1;27;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	141	143	AGT	27;27;27	A,G;G,A;T	25,1;25,1;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	150	152	TAC	26;26;26	T,C;A;C	25,1;25;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	R307A	NONSYN	919	921	AGA	240	242	GCA	8;8;8	G;C;A	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	252	254	GCA	8;8;8	G;C;A	7;8;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	255	257	GAC	8;8;8	G;A;C	8;7;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	261	263	ATC	8;8;8	A;T;C	7;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	267	269	TCG	8;8;8	T;C;G	8;7;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	273	275	GCC	8;8;8	G;C;C	7;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	276	278	AGC	8;8;8	A;G;C	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	279	281	GCC	9;9;9	G;C;C	7;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	180	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	437	16.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	285	287	GTT	10;10;10	G;T;T	10;10;9	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	305	307	GAA	151;153;151	G;A;A	146;148;149	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	716	718	TCA	145;146;144	T;C;A	140;141;138	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	845	847	GTC	130;131;128	G,A;T;C,G	124,1;125;124,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	857	859	TCT	133;132;132	T;C,T;T	130;124,7;131	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1175	1177	GCA	127;126;125	G;C,A;A	125;113,9;121	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	1	SNP	p	G120K	1	.	.	358	360	AAG	551	553	AAG	150;146;147	A;A;G	143;141;140	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	1	SNP	p	A121D	1	.	.	361	363	GAC	554	556	GAC	148;148;147	G,A;A;C	136,3;141;140	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1768	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1385	125.0	1	SNP	p	D121N	0	.	.	361	363	GAC	554	556	GAC	148;148;147	G,A;A;C	136,3;141;140	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6204	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4770	129.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	782	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1078	71.7	1	SNP	p	V57M	1	.	.	169	171	ATG	552	554	ATG	142;143;144	A;T;G	140;141;141	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
